Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
Many individuals with schizophrenia smoke cigarettes. Individuals in the schizophrenic
population often find it difficult to quit smoking. The purpose of this trial is to determine
the safety and effectiveness of bupropion in treating individuals with schizophrenia who
smoke.